Filing Details
- Accession Number:
- 0001209191-20-058406
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-13 20:00:10
- Reporting Period:
- 2020-11-11
- Accepted Time:
- 2020-11-13 20:00:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1718108 | Surface Oncology Inc. | SURF | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1733077 | W. Robert Ross | C/O Surface Oncology, Inc. 50 Hampshire Street, 8Th Floor Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-11 | 595 | $10.05 | 100,405 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020.
Billionaire Hedge Funds
